학술논문
Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naive Patients with ALK plus Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis
Document Type
Journal
Author
Source
Subject
Language
English
ISSN
20059256